ZITA LIM: Open Payments
NPI 1659449536 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,375 in 81 payments from 8 companies in 2025. Trend: 2023 $2,505 · 2024 $10,677 · 2025 $1,375
Food & beverage: $1,275Education: $100
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 65 | $863 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $139 |
| Astellas Pharma US Inc | 2 | $114 |
| Aveo Pharmaceuticals, Inc. | 1 | $88 |
| Eisai Inc. | 3 | $72 |
| Janssen Biotech, Inc. | 2 | $45 |
| TOLMAR, INC. | 1 | $27 |
| pharmaand GmbH | 1 | $27 |
Products named: CABOMETYX, Nubeqa, FOTIVDA, Lenvima, ERLEADA, ELIGARD, Rubraca, Xofigo.
Industry payments across TX — which companies pay providers there.
